| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Tissue Proteins | 7 | 2019 | 503 | 2.390 |
Why?
|
| Laminin | 14 | 2002 | 85 | 2.020 |
Why?
|
| Lung | 20 | 2014 | 1170 | 1.860 |
Why?
|
| Lymphangioleiomyomatosis | 5 | 2016 | 8 | 1.690 |
Why?
|
| Oncogene Proteins | 4 | 2019 | 59 | 1.620 |
Why?
|
| Muscle, Smooth | 10 | 2008 | 354 | 1.600 |
Why?
|
| Fibroblasts | 9 | 2019 | 729 | 1.430 |
Why?
|
| Transforming Growth Factor beta | 5 | 2016 | 301 | 1.340 |
Why?
|
| Mesoderm | 13 | 2002 | 108 | 1.240 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 87 | 0.770 |
Why?
|
| Serum Response Factor | 4 | 2004 | 44 | 0.760 |
Why?
|
| Muscle Development | 3 | 2008 | 41 | 0.710 |
Why?
|
| Immunohistochemistry | 17 | 2016 | 1753 | 0.700 |
Why?
|
| Exosomes | 1 | 2020 | 50 | 0.700 |
Why?
|
| Extracellular Vesicles | 1 | 2020 | 42 | 0.690 |
Why?
|
| Transforming Growth Factor beta3 | 2 | 2019 | 16 | 0.690 |
Why?
|
| Transforming Growth Factor beta2 | 2 | 2019 | 15 | 0.690 |
Why?
|
| Proteomics | 1 | 2020 | 212 | 0.650 |
Why?
|
| Protein Biosynthesis | 3 | 2019 | 378 | 0.620 |
Why?
|
| Pulmonary Fibrosis | 1 | 2019 | 123 | 0.610 |
Why?
|
| Bronchi | 5 | 2002 | 229 | 0.600 |
Why?
|
| Mice | 33 | 2016 | 11352 | 0.590 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2013 | 132 | 0.580 |
Why?
|
| Endothelium, Lymphatic | 1 | 2016 | 10 | 0.570 |
Why?
|
| Cicatrix | 1 | 2016 | 63 | 0.570 |
Why?
|
| Angiomyolipoma | 1 | 2016 | 15 | 0.570 |
Why?
|
| Wound Healing | 4 | 2018 | 344 | 0.560 |
Why?
|
| Cell Differentiation | 14 | 2008 | 1458 | 0.560 |
Why?
|
| Animals | 46 | 2019 | 26581 | 0.520 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2014 | 3 | 0.520 |
Why?
|
| Proteins | 2 | 2020 | 777 | 0.500 |
Why?
|
| Carrier Proteins | 2 | 2008 | 673 | 0.460 |
Why?
|
| Endothelium | 1 | 2013 | 59 | 0.460 |
Why?
|
| Receptors, Progesterone | 1 | 2014 | 167 | 0.450 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 144 | 0.440 |
Why?
|
| Epithelial Cells | 10 | 2001 | 669 | 0.430 |
Why?
|
| Lymphatic Vessels | 1 | 2013 | 68 | 0.430 |
Why?
|
| Cell Size | 6 | 2008 | 65 | 0.420 |
Why?
|
| Homeostasis | 1 | 2013 | 409 | 0.400 |
Why?
|
| Histone Acetyltransferases | 2 | 2008 | 38 | 0.400 |
Why?
|
| Cells, Cultured | 13 | 2013 | 2818 | 0.400 |
Why?
|
| Bleomycin | 2 | 2019 | 98 | 0.390 |
Why?
|
| Basement Membrane | 5 | 1999 | 54 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 3092 | 0.360 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2016 | 114 | 0.350 |
Why?
|
| Peptide Fragments | 2 | 2004 | 460 | 0.350 |
Why?
|
| Collagen | 6 | 2019 | 269 | 0.340 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 3030 | 0.340 |
Why?
|
| Respiratory System | 2 | 2008 | 116 | 0.340 |
Why?
|
| NIH 3T3 Cells | 4 | 2014 | 105 | 0.340 |
Why?
|
| Protein Isoforms | 6 | 2008 | 270 | 0.340 |
Why?
|
| Amino Acid Sequence | 7 | 2014 | 2062 | 0.330 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2008 | 18 | 0.330 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 696 | 0.330 |
Why?
|
| Adipogenesis | 1 | 2008 | 38 | 0.330 |
Why?
|
| Adipocytes | 2 | 2008 | 155 | 0.320 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2013 | 83 | 0.320 |
Why?
|
| Blood Pressure | 1 | 2013 | 1143 | 0.310 |
Why?
|
| Proteoglycans | 3 | 1998 | 121 | 0.310 |
Why?
|
| Blotting, Western | 4 | 2016 | 782 | 0.310 |
Why?
|
| Mice, Knockout | 3 | 2019 | 1924 | 0.310 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 2261 | 0.310 |
Why?
|
| Organ Culture Techniques | 10 | 2001 | 135 | 0.310 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1578 | 0.300 |
Why?
|
| Cell Movement | 4 | 2006 | 758 | 0.300 |
Why?
|
| Mice, Inbred Strains | 9 | 2003 | 307 | 0.300 |
Why?
|
| Stress, Mechanical | 3 | 2005 | 248 | 0.300 |
Why?
|
| Cell Polarity | 2 | 1998 | 115 | 0.290 |
Why?
|
| Alternative Splicing | 3 | 2005 | 201 | 0.280 |
Why?
|
| Humans | 44 | 2020 | 86601 | 0.280 |
Why?
|
| Gene Expression Regulation | 5 | 2014 | 1920 | 0.270 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 273 | 0.270 |
Why?
|
| Myoblasts | 1 | 2005 | 31 | 0.270 |
Why?
|
| RNA, Messenger | 7 | 2013 | 1981 | 0.260 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2004 | 47 | 0.250 |
Why?
|
| Extracellular Matrix | 6 | 2006 | 232 | 0.250 |
Why?
|
| Melanocytes | 1 | 2004 | 56 | 0.250 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2005 | 77 | 0.250 |
Why?
|
| Protein Precursors | 1 | 2004 | 143 | 0.230 |
Why?
|
| Lymphangiomyoma | 1 | 2003 | 1 | 0.230 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2003 | 3 | 0.230 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2001 | 69 | 0.230 |
Why?
|
| Recombinant Proteins | 4 | 2014 | 1014 | 0.230 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 279 | 0.220 |
Why?
|
| Botulinum Toxins | 1 | 2002 | 17 | 0.210 |
Why?
|
| Transfection | 4 | 2006 | 896 | 0.210 |
Why?
|
| Culture Media, Conditioned | 3 | 2018 | 104 | 0.210 |
Why?
|
| Ribonucleoproteins | 1 | 2001 | 38 | 0.200 |
Why?
|
| Tensile Strength | 2 | 2016 | 79 | 0.200 |
Why?
|
| Embryo Implantation | 1 | 2000 | 25 | 0.190 |
Why?
|
| Epithelium | 8 | 2002 | 319 | 0.190 |
Why?
|
| Abortion, Habitual | 1 | 2000 | 33 | 0.190 |
Why?
|
| Trophoblasts | 1 | 2000 | 33 | 0.190 |
Why?
|
| A549 Cells | 1 | 2020 | 39 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2018 | 190 | 0.180 |
Why?
|
| Cell Lineage | 2 | 2016 | 273 | 0.180 |
Why?
|
| Male | 20 | 2019 | 40956 | 0.180 |
Why?
|
| Tretinoin | 3 | 1999 | 126 | 0.180 |
Why?
|
| Stem Cells | 1 | 2002 | 351 | 0.180 |
Why?
|
| Mice, Inbred ICR | 3 | 2005 | 70 | 0.170 |
Why?
|
| Morphogenesis | 6 | 1999 | 192 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2008 | 1197 | 0.170 |
Why?
|
| Cell Adhesion | 7 | 2004 | 420 | 0.170 |
Why?
|
| Female | 22 | 2014 | 44507 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2000 | 206 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 1208 | 0.160 |
Why?
|
| Wound Infection | 1 | 2018 | 17 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 376 | 0.160 |
Why?
|
| Curcumin | 1 | 2018 | 15 | 0.160 |
Why?
|
| Low-Level Light Therapy | 1 | 2018 | 15 | 0.160 |
Why?
|
| Coculture Techniques | 4 | 1999 | 164 | 0.160 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2004 | 67 | 0.160 |
Why?
|
| Heparin | 2 | 1996 | 175 | 0.160 |
Why?
|
| Photosensitizing Agents | 1 | 2018 | 48 | 0.160 |
Why?
|
| Protein Binding | 2 | 2014 | 1456 | 0.160 |
Why?
|
| Hepatitis D | 2 | 1988 | 6 | 0.160 |
Why?
|
| Cell Division | 7 | 2004 | 696 | 0.160 |
Why?
|
| Rats | 8 | 2018 | 3990 | 0.150 |
Why?
|
| Growth Substances | 2 | 1996 | 80 | 0.150 |
Why?
|
| Down-Regulation | 3 | 2004 | 504 | 0.150 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 165 | 0.140 |
Why?
|
| Heparitin Sulfate | 1 | 1996 | 27 | 0.140 |
Why?
|
| Computational Biology | 1 | 2020 | 528 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1990 | 683 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 4 | 1998 | 1376 | 0.140 |
Why?
|
| Methyltransferases | 2 | 2008 | 182 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1996 | 179 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 255 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2232 | 0.130 |
Why?
|
| Sirolimus | 1 | 2016 | 169 | 0.130 |
Why?
|
| Glycoproteins | 1 | 1996 | 234 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 182 | 0.130 |
Why?
|
| Embryonic and Fetal Development | 4 | 2002 | 72 | 0.130 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 49 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2016 | 3241 | 0.130 |
Why?
|
| Muscle Proteins | 3 | 2000 | 132 | 0.130 |
Why?
|
| DNA | 1 | 2000 | 1294 | 0.130 |
Why?
|
| Luciferases | 1 | 2014 | 118 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 736 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1804 | 0.120 |
Why?
|
| Genes, Reporter | 1 | 2014 | 268 | 0.120 |
Why?
|
| Sequence Alignment | 1 | 2014 | 351 | 0.120 |
Why?
|
| Aortography | 1 | 2013 | 63 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2013 | 54 | 0.120 |
Why?
|
| Endothelium, Vascular | 4 | 1991 | 435 | 0.120 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 207 | 0.120 |
Why?
|
| Myxoma | 3 | 1989 | 28 | 0.110 |
Why?
|
| Phenotype | 3 | 2006 | 2377 | 0.110 |
Why?
|
| Hypotension | 1 | 2013 | 70 | 0.110 |
Why?
|
| Heart Neoplasms | 3 | 1989 | 62 | 0.110 |
Why?
|
| Muscle Contraction | 1 | 2013 | 283 | 0.110 |
Why?
|
| Dextrans | 2 | 2003 | 77 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 231 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 2426 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 7 | 2002 | 1041 | 0.110 |
Why?
|
| Aorta | 1 | 2013 | 280 | 0.100 |
Why?
|
| Adult | 11 | 2014 | 25640 | 0.100 |
Why?
|
| Binding Sites | 1 | 2014 | 1098 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 879 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2014 | 597 | 0.100 |
Why?
|
| Actins | 3 | 2004 | 451 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2013 | 712 | 0.100 |
Why?
|
| ErbB Receptors | 1 | 1993 | 485 | 0.090 |
Why?
|
| Pregnancy | 5 | 2000 | 2893 | 0.090 |
Why?
|
| Hepatitis B | 2 | 1988 | 74 | 0.090 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 2004 | 17 | 0.090 |
Why?
|
| Umbilical Veins | 1 | 1989 | 46 | 0.090 |
Why?
|
| Gene Expression | 1 | 2013 | 1284 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 2002 | 735 | 0.080 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2008 | 5 | 0.080 |
Why?
|
| Acetylation | 1 | 2008 | 121 | 0.080 |
Why?
|
| Floxuridine | 1 | 1988 | 11 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2008 | 66 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2008 | 205 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 1990 | 444 | 0.080 |
Why?
|
| Duodenum | 1 | 1988 | 100 | 0.080 |
Why?
|
| Aged | 7 | 2013 | 18402 | 0.080 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 408 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2018 | 297 | 0.080 |
Why?
|
| Histones | 2 | 2008 | 311 | 0.080 |
Why?
|
| Ki-67 Antigen | 2 | 2004 | 64 | 0.070 |
Why?
|
| Drug Combinations | 2 | 1998 | 224 | 0.070 |
Why?
|
| Luteal Cells | 1 | 1986 | 2 | 0.070 |
Why?
|
| Corpus Luteum | 1 | 1986 | 14 | 0.070 |
Why?
|
| Ovarian Cysts | 1 | 1986 | 17 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 214 | 0.070 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2006 | 1 | 0.070 |
Why?
|
| Middle Aged | 8 | 2013 | 25017 | 0.070 |
Why?
|
| Intestinal Perforation | 1 | 1986 | 34 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 1986 | 27 | 0.070 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 1999 | 24 | 0.070 |
Why?
|
| Cross Reactions | 2 | 2000 | 106 | 0.070 |
Why?
|
| Cell Nucleus | 3 | 2004 | 579 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 6501 | 0.070 |
Why?
|
| Eosinophilia | 1 | 1986 | 84 | 0.070 |
Why?
|
| Prostatic Neoplasms | 3 | 2004 | 1720 | 0.070 |
Why?
|
| Skin | 3 | 2018 | 554 | 0.070 |
Why?
|
| Ileum | 1 | 1986 | 159 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2008 | 240 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1991 | 1075 | 0.070 |
Why?
|
| Liver Diseases | 1 | 1988 | 238 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2000 | 268 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 1988 | 797 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 1135 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2000 | 1961 | 0.070 |
Why?
|
| Acetyltransferases | 1 | 2005 | 29 | 0.070 |
Why?
|
| Tetraspanin 30 | 1 | 2004 | 3 | 0.070 |
Why?
|
| RNA Interference | 1 | 2006 | 369 | 0.070 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2005 | 69 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 937 | 0.060 |
Why?
|
| Fibrinolysin | 1 | 2004 | 26 | 0.060 |
Why?
|
| Matrix Metalloproteinases | 1 | 2004 | 28 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2004 | 36 | 0.060 |
Why?
|
| Plasminogen | 1 | 2004 | 41 | 0.060 |
Why?
|
| Dermis | 1 | 2004 | 27 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 1987 | 297 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 55 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 108 | 0.060 |
Why?
|
| Spleen | 2 | 2003 | 430 | 0.060 |
Why?
|
| Skin Aging | 1 | 2004 | 28 | 0.060 |
Why?
|
| Yeasts | 1 | 2004 | 49 | 0.060 |
Why?
|
| Lymphokines | 1 | 2004 | 76 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2002 | 124 | 0.060 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2003 | 11 | 0.060 |
Why?
|
| Lymphocyte Transfusion | 1 | 2003 | 41 | 0.060 |
Why?
|
| Leukemia, B-Cell | 1 | 2003 | 23 | 0.060 |
Why?
|
| Immunization | 1 | 2003 | 158 | 0.060 |
Why?
|
| Pressure | 1 | 2003 | 165 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2004 | 458 | 0.060 |
Why?
|
| 3T3 Cells | 1 | 2002 | 94 | 0.060 |
Why?
|
| Plasmids | 1 | 2003 | 287 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2004 | 439 | 0.050 |
Why?
|
| ADP Ribose Transferases | 1 | 2002 | 4 | 0.050 |
Why?
|
| Peptides | 2 | 1996 | 639 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2002 | 28 | 0.050 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2002 | 31 | 0.050 |
Why?
|
| Cathepsins | 1 | 2002 | 21 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2003 | 170 | 0.050 |
Why?
|
| Cell Transplantation | 1 | 2002 | 47 | 0.050 |
Why?
|
| Graft vs Tumor Effect | 1 | 2002 | 25 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2002 | 41 | 0.050 |
Why?
|
| Serpins | 1 | 2001 | 29 | 0.050 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2001 | 50 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 87 | 0.050 |
Why?
|
| Lysophospholipids | 1 | 2002 | 63 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 1 | 2001 | 2 | 0.050 |
Why?
|
| Calcium | 2 | 1999 | 1156 | 0.050 |
Why?
|
| Cell Communication | 2 | 2004 | 194 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2001 | 19 | 0.050 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2001 | 63 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2001 | 53 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2001 | 256 | 0.050 |
Why?
|
| Gene Library | 1 | 2001 | 130 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2001 | 290 | 0.050 |
Why?
|
| Chorion | 1 | 2000 | 13 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 689 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2000 | 129 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 302 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1991 | 316 | 0.050 |
Why?
|
| Desmin | 1 | 1999 | 10 | 0.050 |
Why?
|
| Digestive System | 1 | 1999 | 42 | 0.050 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 1999 | 21 | 0.050 |
Why?
|
| Thionucleotides | 1 | 1999 | 56 | 0.040 |
Why?
|
| Fetus | 1 | 2000 | 226 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1999 | 27 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 229 | 0.040 |
Why?
|
| Neutrophils | 3 | 1989 | 307 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 85 | 0.040 |
Why?
|
| Myosins | 1 | 1999 | 90 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2000 | 267 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 2004 | 503 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 1989 | 158 | 0.040 |
Why?
|
| Gene Deletion | 1 | 1999 | 329 | 0.040 |
Why?
|
| Cell Line | 1 | 2003 | 2468 | 0.040 |
Why?
|
| Mercuric Chloride | 1 | 1998 | 8 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 1999 | 396 | 0.040 |
Why?
|
| Protein Denaturation | 1 | 1998 | 106 | 0.040 |
Why?
|
| Epidermal Growth Factor | 2 | 1999 | 119 | 0.040 |
Why?
|
| Models, Biological | 2 | 2008 | 1749 | 0.040 |
Why?
|
| Glycerol | 1 | 1998 | 32 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 1999 | 435 | 0.040 |
Why?
|
| Lasers | 1 | 2018 | 106 | 0.040 |
Why?
|
| Israel | 2 | 1988 | 55 | 0.040 |
Why?
|
| Aging | 1 | 2002 | 691 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 2436 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 307 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 286 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1997 | 177 | 0.040 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 73 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 253 | 0.040 |
Why?
|
| Pyrimidines | 1 | 1999 | 370 | 0.040 |
Why?
|
| Heparin Lyase | 1 | 1996 | 4 | 0.040 |
Why?
|
| EGF Family of Proteins | 1 | 1996 | 4 | 0.040 |
Why?
|
| Amphiregulin | 1 | 1996 | 7 | 0.040 |
Why?
|
| Polysaccharide-Lyases | 1 | 1996 | 8 | 0.040 |
Why?
|
| Polymers | 1 | 1998 | 202 | 0.040 |
Why?
|
| RNA | 1 | 2000 | 560 | 0.040 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1996 | 21 | 0.040 |
Why?
|
| Prostate | 1 | 1999 | 377 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 263 | 0.030 |
Why?
|
| Time Factors | 2 | 2001 | 5209 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1685 | 0.030 |
Why?
|
| Base Sequence | 2 | 2002 | 2330 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 2 | 1990 | 31 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 1998 | 295 | 0.030 |
Why?
|
| Kidney | 2 | 1998 | 1241 | 0.030 |
Why?
|
| Mitosis | 2 | 1991 | 153 | 0.030 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2013 | 33 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 85 | 0.030 |
Why?
|
| Biomarkers | 1 | 1998 | 1718 | 0.030 |
Why?
|
| Thiocyanates | 1 | 1991 | 11 | 0.030 |
Why?
|
| Fluoresceins | 1 | 1991 | 43 | 0.030 |
Why?
|
| Binding Sites, Antibody | 1 | 1991 | 49 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1991 | 145 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 526 | 0.030 |
Why?
|
| Exons | 1 | 2013 | 450 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 2013 | 175 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1991 | 163 | 0.020 |
Why?
|
| Fibronectins | 1 | 1991 | 93 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 1990 | 83 | 0.020 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 1990 | 11 | 0.020 |
Why?
|
| Cell Survival | 2 | 1989 | 969 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 1990 | 75 | 0.020 |
Why?
|
| Monocytes | 1 | 1991 | 214 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 332 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 268 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 1988 | 8475 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 1990 | 108 | 0.020 |
Why?
|
| Cytoplasm | 2 | 1988 | 281 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1989 | 116 | 0.020 |
Why?
|
| Mouth Neoplasms | 1 | 1991 | 194 | 0.020 |
Why?
|
| Catheterization | 1 | 1990 | 232 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1989 | 213 | 0.020 |
Why?
|
| Hepatitis Antibodies | 1 | 1988 | 6 | 0.020 |
Why?
|
| Hepatitis Delta Virus | 1 | 1988 | 9 | 0.020 |
Why?
|
| Haplorhini | 1 | 2008 | 81 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1988 | 155 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1990 | 142 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1988 | 34 | 0.020 |
Why?
|
| Disease Progression | 2 | 2004 | 1531 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1988 | 27 | 0.020 |
Why?
|
| Cytosol | 1 | 2008 | 189 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 203 | 0.020 |
Why?
|
| Antibodies | 1 | 1990 | 350 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2008 | 1056 | 0.020 |
Why?
|
| Hepatic Artery | 1 | 1988 | 83 | 0.020 |
Why?
|
| Cholestasis | 1 | 1987 | 47 | 0.020 |
Why?
|
| Factor VIII | 1 | 1987 | 7 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1990 | 427 | 0.020 |
Why?
|
| Hepatitis, Chronic | 1 | 1987 | 5 | 0.020 |
Why?
|
| Endocytosis | 1 | 2008 | 177 | 0.020 |
Why?
|
| Keratins | 1 | 1987 | 63 | 0.020 |
Why?
|
| Vimentin | 1 | 1987 | 44 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1987 | 130 | 0.020 |
Why?
|
| Ileal Diseases | 1 | 1986 | 25 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1987 | 144 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1991 | 556 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2002 | 391 | 0.020 |
Why?
|
| Postpartum Period | 1 | 1986 | 135 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2008 | 666 | 0.020 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1985 | 48 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2356 | 0.020 |
Why?
|
| Chronic Disease | 1 | 1988 | 970 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2004 | 28 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 2270 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2002 | 1047 | 0.020 |
Why?
|
| Child, Preschool | 2 | 1988 | 3611 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1991 | 1169 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 2003 | 84 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2004 | 143 | 0.010 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2002 | 39 | 0.010 |
Why?
|
| Liver | 1 | 1987 | 1229 | 0.010 |
Why?
|
| Actin Cytoskeleton | 1 | 2004 | 192 | 0.010 |
Why?
|
| Cathepsin H | 1 | 2002 | 4 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 87 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2001 | 148 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 2001 | 78 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2003 | 365 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1985 | 374 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 157 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 996 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2002 | 2378 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 543 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 1161 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2001 | 552 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1999 | 27 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1999 | 24 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 927 | 0.010 |
Why?
|
| Cytokines | 1 | 2003 | 776 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1999 | 117 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1991 | 989 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2001 | 1540 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1998 | 123 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 1998 | 94 | 0.010 |
Why?
|
| Regeneration | 1 | 1998 | 143 | 0.010 |
Why?
|
| Child | 1 | 1988 | 6926 | 0.010 |
Why?
|
| Prostatectomy | 1 | 1999 | 471 | 0.010 |
Why?
|
| Adolescent | 1 | 1988 | 8979 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 1565 | 0.010 |
Why?
|
| Insulin | 1 | 1999 | 1160 | 0.010 |
Why?
|
| Leucine | 1 | 1993 | 67 | 0.010 |
Why?
|
| Echocardiography | 2 | 1989 | 911 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1993 | 143 | 0.010 |
Why?
|
| Thrombospondins | 1 | 1991 | 14 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 137 | 0.010 |
Why?
|
| Nephritis, Hereditary | 1 | 1990 | 5 | 0.010 |
Why?
|
| Lupus Nephritis | 1 | 1990 | 78 | 0.010 |
Why?
|
| Phonocardiography | 1 | 1989 | 3 | 0.010 |
Why?
|
| Sound | 1 | 1989 | 26 | 0.010 |
Why?
|
| Heart Septum | 1 | 1989 | 45 | 0.010 |
Why?
|
| Polyanetholesulfonate | 1 | 1989 | 1 | 0.010 |
Why?
|
| Streptolysins | 1 | 1989 | 5 | 0.010 |
Why?
|
| Glucose Oxidase | 1 | 1989 | 7 | 0.010 |
Why?
|
| Phospholipases | 1 | 1989 | 10 | 0.010 |
Why?
|
| Lysophosphatidylcholines | 1 | 1989 | 18 | 0.010 |
Why?
|
| Chromium | 1 | 1989 | 17 | 0.010 |
Why?
|
| Catalase | 1 | 1989 | 48 | 0.010 |
Why?
|
| Free Radicals | 1 | 1989 | 73 | 0.010 |
Why?
|
| Dogs | 1 | 1990 | 685 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1990 | 232 | 0.010 |
Why?
|
| Rats, Nude | 1 | 1988 | 22 | 0.010 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1988 | 24 | 0.010 |
Why?
|
| Microvilli | 1 | 1988 | 43 | 0.000 |
Why?
|
| Myocardial Contraction | 1 | 1989 | 244 | 0.000 |
Why?
|
| Whole-Body Irradiation | 1 | 1988 | 63 | 0.000 |
Why?
|
| alpha-Fetoproteins | 1 | 1988 | 45 | 0.000 |
Why?
|
| Intercellular Junctions | 1 | 1988 | 68 | 0.000 |
Why?
|
| Bile Ducts | 1 | 1987 | 59 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1987 | 65 | 0.000 |
Why?
|
| Heart Atria | 1 | 1989 | 250 | 0.000 |
Why?
|
| Myocardium | 1 | 1990 | 529 | 0.000 |
Why?
|
| Heart | 1 | 1990 | 539 | 0.000 |
Why?
|
| Fibrosis | 1 | 1987 | 203 | 0.000 |
Why?
|
| Angiography | 1 | 1987 | 208 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1988 | 790 | 0.000 |
Why?
|
| Infant, Premature | 1 | 1987 | 290 | 0.000 |
Why?
|
| Infant | 1 | 1987 | 3045 | 0.000 |
Why?
|